New Weight Loss Combo
May 22, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Thi Vietthi Huynh, 2022 PharmD Candidate, Lake Erie College of Osteopathic Medicine – School of Pharmacy
A combined pharmacological therapy showed efficacy in bodyweight reduction without lifestyle, diet, physical activity changes or surgery.
Weight management is essential in reducing risk factors of many chronic diseases, such as cardiovascular disease, obesity, type 2 diabetes, asthma, sleep apnea, etc. Weight reduction of at least 5% of current weight, or even >10%, is highly recommended in managing dangerous chronic diseases mentioned above. Many studies have been conducted to ascertain effective and safe pharmaceutical products supporting weight loss. Recently, Dr. Lone B. Enebo and his colleagues published their discovery about a drug combination that can contribute to weight management: cagrilintide and semaglutide 2.4mg....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.